NUCLEUS stock news
This page provides real-time market news, earnings updates, and company announcements related to Nucleus Software Exports Limited (NUCLEUS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-14 08:57 IST
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Finviz2026-03-06 13:34:29
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Finviz2026-03-09 11:03:49
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Finviz2026-03-09 11:03:49
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Finviz2026-03-11 17:04:02
NUCLEUS stock price change
On the last trading day, NUCLEUS stock closed at 786.45 INR, with a price change of 3.90% for the day.
Trade stock perpsNUCLEUS stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more